Ethyl 2-(2-methyl-5-nitro-1H-imidazol-1-yl)acetate

Catalog No. :
ACMHXN283
CAS No. :
1016-40-6
Molecular Formula :
C8H11N3O4
Molecular Weight :
213.19

IUPAC Name:ethyl 2-(2-methyl-5-nitro-1H-imidazol-1-yl)acetate

Ethyl 2-(2-methyl-5-nitro-1H-imidazol-1-yl)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 2-(2-methyl-5-nitro-1H-imidazol-1-yl)acetate
IUPAC Nameethyl 2-(2-methyl-5-nitro-1H-imidazol-1-yl)acetate
MDL No.MFCD01161102
Molecular FormulaC8H11N3O4
Molecular Weight213.19
SMILESO=C(OCC)CN1C([N+]([O-])=O)=CN=C1C
InChI KeyCKGGIKOPFUMXET-UHFFFAOYSA-N
Synonym2-Methyl-5-nitro-1H-imidazole-1-acetic acid ethyl ester;E90110;Ethyl 2-methyl-5-nitro-1H-imidazole-1-acetate;ethyl 2-(2-methyl-5-nitro-1H-imidazole-1-yl)acetate;Metronidazole Impurity 11;1H-Imidazole-1-acetic acid, 2-methyl-5-nitro-, ethyl ester;Metronidazole EP Impurity J;Metronidazole Impurity 40
CAS No.1016-40-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACMHXN283 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEFRL053 route compound structure diagram
    ACEFRL053696-23-1 In Stock
  4. Then
  5. ACMHXN283 route product structure diagram
    ACMHXN2831016-40-6
Inquiry

2. ACMHXN283 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEFRL053 route compound structure diagram
    ACEFRL053696-23-1 In Stock
  4. Then
  5. ACMHXN283 route product structure diagram
    ACMHXN2831016-40-6
Inquiry

Comments (0)